Mutant p53 Mediates Sensitivity to Cancer Treatment Agents in Oesophageal Adenocarcinoma Associated with MicroRNA and SLC7A11 Expression
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
In: International Journal of Molecular Sciences 22 (2021) 11, 5547, 1-25
- Event
-
Veröffentlichung
- (where)
-
Münster
- (who)
-
Universitäts- und Landesbibliothek Münster
- (when)
-
2021
- Creator
-
Eichelmann, Ann-Kathrin
Mayne, George C.
Chiam, Karen
Due, Steven L.
Bastian, Isabell
Butz, Frederike
Wang, Tingting
Sykes, Pamela J.
Clemons, Nicholas J.
Liu, David S.
Michael, Michael Z.
Karapetis, Christos S.
Hummel, Richard
Watson, David I.
Hussey, Damian J.
- DOI
-
10.3390/ijms22115547
- URN
-
urn:nbn:de:hbz:6-37039618477
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:46 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Eichelmann, Ann-Kathrin
- Mayne, George C.
- Chiam, Karen
- Due, Steven L.
- Bastian, Isabell
- Butz, Frederike
- Wang, Tingting
- Sykes, Pamela J.
- Clemons, Nicholas J.
- Liu, David S.
- Michael, Michael Z.
- Karapetis, Christos S.
- Hummel, Richard
- Watson, David I.
- Hussey, Damian J.
- Universitäts- und Landesbibliothek Münster
Time of origin
- 2021
Other Objects (12)
MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
Quercetin-induced microRNA regulation of pancreatic ductal adenocarcinoma
How mutant p53 empowers Foxh1 fostering leukaemogenesis?
Exploring mutant p53 targeting strategies for cancer therapy
Aldo-keto reductase 1C3 mediates chemotherapy resistance in esophageal adenocarcinoma via ROS detoxification
The accumulation of mutant p53 in human cancer cells
Identification of Small Molecules that Modulate Mutant p53 Condensation
Funktionelle Charakterisierung carboxyterminaler und aminoterminaler Mutanten des Tumorsuppressorproteins p53
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
Etablierung und Charakterisierung zweier zellulärer Systeme zur Unterscheidung zwischen p53 Wildtyp- und p53 Mutanten-Funktion
Analyse der Expression von Mutanten p53 in normalen und Tumorzellen
Analyse der Expression von Mutanten p53 in normalen und Tumorzellen
MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
Quercetin-induced microRNA regulation of pancreatic ductal adenocarcinoma
How mutant p53 empowers Foxh1 fostering leukaemogenesis?
Exploring mutant p53 targeting strategies for cancer therapy
Aldo-keto reductase 1C3 mediates chemotherapy resistance in esophageal adenocarcinoma via ROS detoxification
The accumulation of mutant p53 in human cancer cells
Identification of Small Molecules that Modulate Mutant p53 Condensation
Funktionelle Charakterisierung carboxyterminaler und aminoterminaler Mutanten des Tumorsuppressorproteins p53
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
Etablierung und Charakterisierung zweier zellulärer Systeme zur Unterscheidung zwischen p53 Wildtyp- und p53 Mutanten-Funktion
Analyse der Expression von Mutanten p53 in normalen und Tumorzellen
Analyse der Expression von Mutanten p53 in normalen und Tumorzellen
MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
Quercetin-induced microRNA regulation of pancreatic ductal adenocarcinoma
How mutant p53 empowers Foxh1 fostering leukaemogenesis?
Exploring mutant p53 targeting strategies for cancer therapy
Aldo-keto reductase 1C3 mediates chemotherapy resistance in esophageal adenocarcinoma via ROS detoxification
The accumulation of mutant p53 in human cancer cells
Identification of Small Molecules that Modulate Mutant p53 Condensation
Funktionelle Charakterisierung carboxyterminaler und aminoterminaler Mutanten des Tumorsuppressorproteins p53
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
Etablierung und Charakterisierung zweier zellulärer Systeme zur Unterscheidung zwischen p53 Wildtyp- und p53 Mutanten-Funktion
Analyse der Expression von Mutanten p53 in normalen und Tumorzellen